newsfilter
← Latest News
GlobeNewswire·

Galecto Reports First Quarter Operating and Financial Results

BOSTON, April 28, 2023 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ:GLTO), a clinical-stage biotechnology company and world leader in galectin biology focused on the development of novel treatments for fibrosis and